Janus Henderson Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-56,831
| Closed | -$99.7K | – | 2655 |
|
2023
Q1 | $99.7K | Buy |
56,831
+32,100
| +130% | +$56.3K | ﹤0.01% | 2616 |
|
2022
Q4 | $77.5K | Sell |
24,731
-24,731
| -50% | -$77.5K | ﹤0.01% | 2375 |
|
2022
Q3 | $244K | Buy |
49,462
+24,633
| +99% | +$122K | ﹤0.01% | 2303 |
|
2022
Q2 | $103K | Buy |
24,829
+108
| +0.4% | +$448 | ﹤0.01% | 2467 |
|
2022
Q1 | $143K | Buy |
24,721
+8
| +0% | +$46 | ﹤0.01% | 2509 |
|
2021
Q4 | $185K | Buy |
24,713
+12,428
| +101% | +$93K | ﹤0.01% | 2414 |
|
2021
Q3 | $111K | Buy |
+12,285
| New | +$111K | ﹤0.01% | 2142 |
|